REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulation studies for In Vitro Diagnostic Use.PRINCIPLE OF THE PROCEDURECoagulation Control 2 is tested in the same manner as citrated patient plasma samples to assess the performance of each assay run, for the parameters. Testing variables in each laboratory, including equipment, reagents, and technique may influence control recovery. Although an expected range is provided for each parameter, laboratories should establish their own expected range for their particular instrument-reagent system. Refer to Package Insert.

SysCOR-40 Control Kit is a system control convenience kit containing 20 normal and 20 abnormal plasma controls to assist with instrument correlations and reagent crossover studies.

George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)

George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)

George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor.

George King Factor XIII Deficient plasma is fresh frozen human plasma derived from a congenital Factor XIII deficient donor.

George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor.

George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.

George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma.

George King von Willebrand, Type 2B, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand aG in citrated plasma.

George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma

George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 3. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma.

George King von Willebrand plasma, Type 2A, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.

George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.

George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.

George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).

George King Positive Lupus Anticoagulant is citrated fresh frozen human plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).

For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.

Positive control for LA 10 x 0.5 ml

Positive control for LA 10 x 1 ml

Normal Control 10 x 1 ml

Abnormal Control L-1 10 x 1 ml

Abnormal Control L-2 10 x 1 ml

Venom Screening test of LA 10 x 2 ml

Venom Confirmatory test for LA 10 x 1 ml

For use as control in citrated coagulation systems

For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin

For use as a high level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin

LA Control High is a high positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers

LA Control Low is a low positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers

Assayed control used to monitor the performance of coagulation assays in the pathological range